Wyeth Pharmaceuticals will be conducting a clinical trial to evaluate the use of pantoprazole (Protonix) in children ages 1 to 5. This national study will seek patients with endoscopically proven symptomatic gastroesophageal reflux disease (GERD). E-mail the organizer for information on when the study will officially begin recruiting.
Read moreInsurance company authorization of medications can be challenging for both patients and physicians. Proton pump inhibitors, because of... Read more »
Yes, acid-reducing medications can cause bone loss. Many medications and medical disorders can cause bone loss; but in this article... Read more »
What can I do to avoid having attacks of esophageal reflux this time of the year? With the holidays just around the corner, whether you... Read more »
This is a study to determine the safety and tolerability of pantoprazole (Protonix) in infants between the ages 1 month through 11 months with... Read more »
This is a study to determine the minimal clinical difference in gastroesophageal reflux disorder (GERD) patients using pantoprazole (Protonix) versus... Read more »
Source: First DataBank
Generic Name: PANTOPRAZOLE DELAYED-RELEASE - ORAL Pronounced: (pan-TOE-pruh-zole) Side Effects Headache, diarrhea, nausea, vomiting, or... Read more »
Source: First DataBank
Generic Name: LANSOPRAZOLE DELAYED-RELEASE SUSPENSION - ORAL Pronounced: (lan-SO-pruh-zole) Side Effects Constipation, diarrhea, or headache may... Read more »
Source: First DataBank
Generic Name: OMEPRAZOLE DELAYED-RELEASE CAPSULE - ORAL Pronounced: (oh-MEH-pruh-zole) Side Effects Constipation, cough, dizziness or back pain... Read more »